RAP
Click for more information
0.00% 20.5¢ resapp health limited

Ann: Clinical study to develop COVID-19 screening test, page-2

  1. Slykes
    1,605 Posts.
    lightbulb Created with Sketch. 202
    clock Created with Sketch.
    11/03/21
    10:11
    Post #: 51680634
    About time, though I can't get excited about another study until there's positive results.
    Here's hoping at least and good to see there's some action going on in the USA regardless of the previous FDA crapola.
    RAP Price at posting: 5.8¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 4  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

RMS Ramelius boosts WA gold portfolio with stake in Spartan
right-arrow Created with Sketch.
SXL Southern Cross says no to buy up of Australian Community Media assets
right-arrow Created with Sketch.
NIM Nimy extends sulphide targets at Mons with new anomalies identified
right-arrow Created with Sketch.
HMD HeraMED delivers digital maternity care to select clinics with Telstra
right-arrow Created with Sketch.
IMU Imugene doses first cancer patient in Oasis trial
right-arrow Created with Sketch.
NEWS Money and Investing: Talking the minefield of divorce & family law
right-arrow Created with Sketch.
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.